Sign In
Buy PEPG
$1.42
-0.0300 (-2.07%)
At Close: Jun 03, 2026
BOSTON, Sept. 01, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming t
PepGen Inc (PEPG) Q4 2022 Earnings Call Transcript
10:58am, Saturday, 25'th Mar 2023
PepGen Inc (NASDAQ:PEPG ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Noel Donnelly - Chief Financial Officer James McArthur - President and Chief Executive Officer
PepGen to Host Fourth Quarter and Full Year 2022 Financial Results Call
08:00am, Thursday, 16'th Mar 2023
BOSTON, March 16, 2023 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming t
PepGen, Inc. (PEPG) Is a Great Choice for 'Trend' Investors, Here's Why
10:32am, Monday, 27'th Feb 2023
PepGen, Inc. (PEPG) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through
Here's Why Momentum in PepGen, Inc. (PEPG) Should Keep going
10:15am, Tuesday, 31'st Jan 2023
PepGen, Inc. (PEPG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through o
What Makes PepGen, Inc. (PEPG) a Good Fit for 'Trend Investing'
10:32am, Monday, 21'st Nov 2022
PepGen, Inc. (PEPG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through o
3 IPO stocks to watch in September: PEPG, PFHC, HNVR
03:45am, Tuesday, 06'th Sep 2022
Initial public offerings (IPOs) are often the most common route companies use to hit the public markets and raise money
Biotech Public Offerings at 10-Year Low
04:56pm, Monday, 11'th Jul 2022
No matter how you slice it, this has been a poor year for biotechnology stocks. Not only is the SPDR S&P Biotech ETF ( XBI , Financial) down nearly 29% year to date, but biotech initial public offerin
It's Time To Nibble On These Two Recent IPOs
10:10am, Tuesday, 31'st May 2022
It's hard to know what to buy and what to sell with market conditions the way they are but it looks like a good time to start nibbling on these two recent IPOs. Bausch + Lomb (NYSE: BLCO) and PepGen (
Andreas Halvorsen's Firm Packs Into PepGen and Mastercard
06:08pm, Monday, 23'rd May 2022
Andreas Halvorsen (Trades, Portfolio), founding partner and chief investment officer of Viking Global Investors LP, disclosed in a regulatory SEC 13G filing that his firm entered positions in PepGen I
